Medical News

RSS

New evidence supports possible link between XMRV and prostate cancer

Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.

13 Oct 2010

USAID awards $15 million grant to Tufts University for CRSP program

Eileen T. Kennedy, DSc, Dean of the Friedman School of Nutrition Science and Policy at Tufts University announced today that the school has been awarded two grants totaling $15 million by the United States Agency for International Development (USAID). The USAID "Leader with Associates (LWA) Award" was granted to the school to serve as the Management Entity for a new Nutrition Collaborative Research Support Program (CRSP) in Africa and Asia. This is the first CRSP to be awarded by USAID in nearly 25 years.

13 Oct 2010

World Economic Forum index ranks countries by gender disparities

An index issued Tuesday by the World Economic Forum (WEF) ranked 134 countries according to how much they had reduced gender disparities over the past year in the areas of economic participation, education, political empowerment and health, the New York Times reports.

13 Oct 2010

SAMHSA awards State Incentive Grants for substance abuse prevention

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.

13 Oct 2010

Metabolic screening before conception predicts development of diabetes in subsequent pregnancy

Cardio-metabolic risk factors such as high blood sugar and insulin, and low high density lipoprotein cholesterol that are present before pregnancy, predict whether a woman will develop diabetes during a future pregnancy, according to a Kaiser Permanente study in the current issue of the American Journal of Epidemiology.

13 Oct 2010

Some states snub health reform; in others, election will decide fate of law's implementation

Politico reports that races at the state level could affect the health law more than congressional races. Governors who oppose the legislation can refuse to set up pieces of the law, such as the state-based insurance exchanges where most Americans will purchase coverage beginning in 2014.

13 Oct 2010

Infection during pregnancy linked to increased risk for neurodevelopmental disorders in fetus

A pregnant woman's immune response to viral infections may induce subtle neurological changes in the unborn child that can lead to an increased risk for neurodevelopmental disorders including schizophrenia and autism. Research published in the online journal mBio- provides new insights into how this may happen and suggests potential strategies for reducing this risk.

13 Oct 2010

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

Donor kidneys can be successfully transplanted even if there is strong tissue incompatibility between donor and recipient. An interdisciplinary working group headed by Dr. Christian Morath, senior consultant at the Department of Nephrology at Heidelberg University Hospital (Medical Director: Professor Dr. Martin Zeier) and Professor Dr. Caner S-sal, head of antibody laboratory in the Department of Transplantation Immunology, showed in a study of 34 sensitized high-risk patients that the success rate in these patients was not different from the success rate of patients with a low immunological risk.

13 Oct 2010

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

ERYtech Pharma is pleased to announce it has signed a collaborative research agreement with Genzyme Corporation to explore the feasibility of developing a novel therapeutic enzyme formulation using ERYtech's proprietary technology.

13 Oct 2010

Kuwait Healthy Life Study to examine metabolic health in children

In the face of a dramatic worldwide increase in adolescent obesity and Type 2 diabetes, The Forsyth Institute today announced a research alliance with the Dasman Diabetes Institute of Kuwait to initiate studies that could lay a scientific basis for prevention. This collaboration, called The Kuwait Healthy Life Study, will examine conditions in children that predispose them to obesity and Type 2 diabetes.

13 Oct 2010

CyDex terminates joint development agreement on Captisol-enabled clopidogrel with Prism Pharmaceuticals

CyDex Pharmaceuticals, Inc. today announced a mutual decision with Prism Pharmaceuticals to terminate their existing joint development agreement on novel Captisol-enabled® intravenous formulations of clopidogrel. This provides CyDex with full development and commercialization rights to the product candidate - an injectable formulation of clopidogrel. Clopidogrel is the active ingredient in PLAVIX®, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb Company and Sanofi-Aventis, Inc.

13 Oct 2010

Boehringer Ingelheim awards milestone payment to Xencor

Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.

13 Oct 2010

CEL-SCI receives Taiwanese IRB approval for Multikine Phase III trial in head and neck cancer

CEL-SCI Corporation announced today it has received approval from the first Taiwanese Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.

13 Oct 2010

NHC enter agreement with Attain to offer new program for IVF fertility treatments

IntegraMed America, Inc. the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced that its Attain Fertility Centers division has entered into an agreement with The New Hope Center for Reproductive Medicine (NHC) to begin offering the Attain IVF family of specialty financing Programs.

13 Oct 2010

DoD awards $1.5 million grant to study nanoemulsion-based therapies for preventing burn wound infections

Researchers from NanoBio Corporation and the University of Michigan Medical School today announced the receipt of a $1.5 million grant from the Department of Defense (DoD) to study the use of nanoemulsion-based therapies for protection against burn and wound infections.

13 Oct 2010

Investigators wondering: Fraud, bad medicine or Union manuevering at Calif. hospital chain?

The Los Angeles Times reports that state and federal investigators are trying to determine whether "a serious health problem or multimillion-dollar Medicare fraud" is behind a reported spike in blood poisoning cases at hospitals operated by Prime Healthcare Services, "a Southern California hospital chain known for aggressive billing practices and cost-cutting."

13 Oct 2010

Retina Implant announces opening of new manufacturing plant in Tübingen-Reutlingen

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the opening of a new manufacturing plant to meet anticipated demand for their implants. The company's second human clinical trial will be expanding outside of Germany in early 2011 to European countries including the U.K. and Italy and discussions are underway for potential clinical trials in the United States and Asia. Also looking ahead, the new facility meets manufacturing capabilities required for CE mark approval.

13 Oct 2010

MTN-007 phase trial evaluates vaginal microbicide to prevent rectal transmission of HIV

Tenofovir gel, a vaginal microbicide that has shown promise for preventing HIV through vaginal sex, is being tested in a new trial looking at its safety and acceptability when used rectally. The results of the study, being led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), will help determine if the gel should be evaluated further for its potential to prevent HIV among both men and women who engage in receptive anal intercourse.

13 Oct 2010

Redesigned version of CTC-Chip effective in capturing rare circulating tumor cells

A redesigned version of the CTC-Chip a microchip-based device for capturing rare circulating tumor cells (CTCs) appears to be more effective and should be easier to manufacture than the original. Called the HB-(herringbone) Chip, the new device also may provide more comprehensive and easily accessible data from captured tumor cells.

13 Oct 2010

Vocera acquires Clinical Health Communications and Integrated Voice Solutions

Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.

13 Oct 2010

Medical News

New evidence supports possible link between XMRV and prostate cancer

USAID awards $15 million grant to Tufts University for CRSP program

World Economic Forum index ranks countries by gender disparities

SAMHSA awards State Incentive Grants for substance abuse prevention

Metabolic screening before conception predicts development of diabetes in subsequent pregnancy

Some states snub health reform; in others, election will decide fate of law's implementation

Infection during pregnancy linked to increased risk for neurodevelopmental disorders in fetus

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

Kuwait Healthy Life Study to examine metabolic health in children

CyDex terminates joint development agreement on Captisol-enabled clopidogrel with Prism Pharmaceuticals

Boehringer Ingelheim awards milestone payment to Xencor

CEL-SCI receives Taiwanese IRB approval for Multikine Phase III trial in head and neck cancer

NHC enter agreement with Attain to offer new program for IVF fertility treatments

DoD awards $1.5 million grant to study nanoemulsion-based therapies for preventing burn wound infections

Investigators wondering: Fraud, bad medicine or Union manuevering at Calif. hospital chain?

Retina Implant announces opening of new manufacturing plant in Tübingen-Reutlingen

MTN-007 phase trial evaluates vaginal microbicide to prevent rectal transmission of HIV

Redesigned version of CTC-Chip effective in capturing rare circulating tumor cells

Vocera acquires Clinical Health Communications and Integrated Voice Solutions

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News